A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 1999

Study Completion Date

August 31, 2000

Conditions

Candidiasis, OralGastrointestinal DiseasesStomatitis

Interventions

DRUG

Nystatin

Trial Locations (1)

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH